-
2025-521884-12-00
5
2026-03-19
First line triple-negative breast cancer (TNBC)
-
2024-519579-24-00
5
2026-02-26
Classic Congenital Adrenal Hyperplasia
-
2025-521558-40-00
5
2026-02-12
Pulmonary Hypertension Associated with Interstitial Lung Disease
-
2023-507525-42-00
5
2025-12-23
Endometrial cancer
-
2025-520979-13-00
5
2025-12-18
Patients with HR+ HER2- early breast cancer at intermediate risk of re
-
2024-519901-36-00
5
2025-12-17
Patients with resected stage II-IIIA non-small cell lung cancer (NSCLC
-
2025-520982-39-00
5
2025-12-09
Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-
-
2024-516906-47-00
10
2025-11-28
Locally Advanced or Metastatic Urothelial Carcinoma
-
2025-521775-31-00
5
2025-11-12
Stage IB-IIIA NSCLC Patients with uncommon EGFR Mutations
-
2024-512753-24-00
5
2025-08-05
Acute Myeloid Leukemia (AML)
-
2024-516616-24-00
5
2025-07-23
Acromegaly
-
2023-507936-20-00
5
2025-05-05
Acute myeloid leukemia
-
2023-505172-29-00
4
2025-04-24
Resectable Non-small Cell Lung Cancer
-
2024-514801-69-00
4
2025-04-02
Thyroid Eye Disease
-
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
-
2023-507097-41-01
5
2025-03-20
Patients with limited-stage small cell lung cancer (LS-SCLC)
without
-
2024-513018-36-00
5
2025-03-06
Lung Diseases, Interstitial
-
2024-516282-37-00
4
2025-02-18
Breast cancer
-
2024-519132-17-00
4
2025-01-29
NON-METASTATIC UNRESECTABLE INTRA-HEPATIC CHOLANGIOCARCINOMA
-
2024-519113-59-00
4
2024-11-20
Hepatocellular carcinoma
-
2024-517099-39-00
4
2024-11-18
Newly diagnosed transplant ineligible multiple myeloma
-
2024-514799-42-00
4
2024-11-05
IDIOPATHIC PULMONARY FIBROSIS
-
2024-517004-11-00
5
2024-10-22
Chronic pulmonary aspergillosis
-
2024-515456-20-00
4
2024-08-13
Hepato carcinoma cancer